Skip to main content

Safir Anand, Ritu Bhargava speak to IBLJ on why India’s unicorns choosing foreign shores

Senior Partner Safir Anand and Lead Managing Associate Ritu Bhargava, explain to Aditya Rangroo of India Business Law Journal (IBLJ) why India’s best startups have chosen foreign shores and whether it’s possible to stem this outflow.

“India’s regulatory landscape is improving but still has challenges in bureaucratic procedures, stringent compliance requirements, and inconsistent policy implementation. In contrast, countries like Singapore, the US, and the UK offer more business-friendly environments with streamlined regulatory processes, better IP protections, and favourable tax regimes, allowing startups to focus on innovation and growth,” Anand and Bhargava share in the IBLJ article titled ‘Why India’s Unicorns Have Bolted’.

Anand and Bhargava say ease of access to venture capital is another reason that countries like the US, particularly Silicon Valley, attract investors with a high-risk appetite for new technologies and innovative business models. They say an international domicile “enhances a startup’s credibility and attractiveness to global investors.

Read it here

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 11, 2026

Think about the apps you use every day. Their visual identity is often the first thing you recognise: the arrangement of icons, navigation menus, buttons,

Can You Patent the Look of an App? GUI and Icon Protection in India
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on Chambers’ By: Dhruv Anand, Dhananjay Khanna and Bhavya Verma It will not be an exaggeration to say that there has been an explosion

PERSONALITY RIGHTS – CURRENT TRENDS
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on India Business Law Journal’ By: Shantanu Sahay and Pratyush Acharya As India moved towards full implementation of the Digital Personal

Treatment of legacy personal data under the DPDPA
News & Updates, Thought Leadership
•
Nov 07, 2026

Pharmaceutical innovation and access to medicines are closely connected aspects of public health. While patent protection can encourage investment in research

Can Public Health Override a Pharmaceutical Patent? The BPaL Patent Dispute in India